Vinorelbine and Diabetes - a phase IV clinical study of FDA data

Summary:

Diabetes is reported as a side effect among people who take Vinorelbine (vinorelbine), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Docetaxel, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Diabetes when taking Vinorelbine. It is created by eHealthMe based on reports of 6,375 people who have side effects when taking Vinorelbine from the FDA, and is updated regularly.

What is Vinorelbine?

Vinorelbine has active ingredients of vinorelbine. eHealthMe is studying from 6,381 Vinorelbine users. Check the latest studies of Vinorelbine.

What is Diabetes?

Diabetes is found to be associated with 2,009 drugs and 2,855 conditions by eHealthMe. Check the latest studies of Diabetes.

On Jul, 17, 2026

6,375 people reported to have side effects when taking Vinorelbine.
Among them, 22 people (0.35%) have Diabetes.

Among these 22 people:

How long have people been on Vinorelbine when they have Diabetes? *

What is the gender of people who have Diabetes when taking Vinorelbine? *

female: 15 %
male: 85 %

What is the age of people who have Diabetes when taking Vinorelbine? *

What are other drugs people take besides Vinorelbine? *

What are other side effects people have besides Diabetes? *

Thrombocytopenia (decrease of platelets in blood): 16 people, 72.73%
Diabetic Ketoacidotic Hyperglycaemic Coma: 14 people, 63.64%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 12 people, 54.55%
Malignant Neoplasm Progression (cancer tumour came back): 12 people, 54.55%
Metastases To The Mediastinum (cancer spreads to mediastinum): 9 people, 40.91%
Lung Cancer Metastatic (lung cancer spreads to other parts): 9 people, 40.91%
Lung Neoplasm Malignant (cancer tumour of lung): 9 people, 40.91%
Metastases To Lymph Nodes (cancer spreads to lymph node): 9 people, 40.91%
Metastatic Neoplasm (spreadable cancer tumour): 9 people, 40.91%
Diarrhea: 4 people, 18.18%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 19 people, 86.36%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 5 people, 22.73%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 3 people, 13.64%
Pleural Infection (infection of membrane of lungs): 3 people, 13.64%
Pancreatitis Chronic (chronic inflammation of pancreas): 3 people, 13.64%
Oral Fungal Infection: 3 people, 13.64%
Neoplasm Malignant (cancer tumour): 3 people, 13.64%
Metastases To Central Nervous System (cancer spreads to central nervous system): 3 people, 13.64%
Metastases To Adrenals (cancer spreads to adrenal gland of kidney): 3 people, 13.64%
Intestinal Infarction (intestinal tissue death): 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Vinorelbine and have Diabetes?

- Check whether Diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vinorelbine:

Vinorelbine (6,381 reports)

Diabetes treatments and more:

Diabetes (466,613 reports)

Browse all side effects of Vinorelbine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diabetes:

Diabetes (2,009 drugs)

Browse all the conditions that are associated with Diabetes:

Diabetes (2,855 conditions)

Related publications that referenced our studies

Mohammad MM, Syrigos KN, Saif MW, "Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma", Case reports in dermatological medicine, 2013 Sep .
Mohammad MM, Syrigos KN, Saif MW, "Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma", Case reports in dermatological medicine, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on vinorelbine (the active ingredients of Vinorelbine) and Vinorelbine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.